Skip to content

Evaluation of the Effects of Test Food Consumption on Performance

Evaluation of the Effects of Test Food Consumption on Performance - Evaluation of the Effects of Test Food Consumption on Performance

Status
Active, not recruiting
Phases
Unknown
Study type
Interventional
Source
JPRN
Registry ID
JPRN-UMIN000055078
Enrollment
50
Registered
2025-07-26
Start date
2024-07-28
Completion date
Unknown
Last updated
2026-06-29

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Male/female adults

Interventions

Consumption of the test food (3 tablets a day) for 8 weeks Consumption of the placebo food (3 tablets a day) for 8 weeks

Sponsors

CPCC Company Limited
Lead Sponsor

Eligibility

Sex/Gender
All

Inclusion criteria

Inclusion criteria: 1. Men and women aged 25 to 49 years at the time of consent. 2. Subjects who have a habit of exercising for more than 5 hours per week. 3. Subjects who have perceived poor sleep quality for more than one month prior to consent acquisition. 4. Subjects who have perceived physical fatigue for more than one month prior to consent acquisition. 5. Subjects who can give informed consent to partake in this study, after being provided with an explanation of the protocol detail.

Exclusion criteria

Exclusion criteria: 1. Subjects currently undergoing medication or outpatient treatment for any serious disease, or those with a history of serious disease. 2. Subjects who cannot maintain their exercise habits and dietary habits from before the study during the trial period. 3. Subjects who are prone to diarrhea or have a weak stomach when consuming dairy products or foods containing lactic acid bacteria in excess. 4. Subjects with extremely irregular lifestyle habits, such as diet and sleep. 5. Subjects who are participating in the other clinical trials and/or who have participated in the other clinical trials within 4 weeks prior to the current trial and/or who are planning to participate in the other clinical trials. 6. Females who are pregnant or lactating, and females who could become pregnant during trial period. 7. Subjects with allergies to medications and/or food. 8. Subjects deemed unsuitable for participation in the trial by the study representative or the principal investigator.

Design outcomes

Primary

MeasureTime frame
Subjective Mood Questionnaire

Countries

Japan

Contacts

Public ContactMasanori Numa

CPCC Company Limited Clinical Planning Department

cpcc-contact@cpcc.co.jp03-6225-9001

Outcome results

None listed

Source: JPRN (via WHO ICTRP) · Data processed: Jul 3, 2026